136 related articles for article (PubMed ID: 21244753)
21. Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.
Galuppo M; Di Paola R; Mazzon E; Genovese T; Crisafulli C; Paterniti I; Cuzzocrea E; Bramanti P; Kapoor A; Thiemermann C; Cuzzocrea S
J Inflamm (Lond); 2010 Feb; 7():12. PubMed ID: 20167109
[TBL] [Abstract][Full Text] [Related]
22. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
23. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
24. PPAR-β/δ activation promotes phospholipid transfer protein expression.
Chehaibi K; Cedó L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vázquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escolà-Gil JC
Biochem Pharmacol; 2015 Mar; 94(2):101-8. PubMed ID: 25662586
[TBL] [Abstract][Full Text] [Related]
25. Emerging role of PPAR-β/δ in inflammatory process associated to experimental periodontitis.
Di Paola R; Briguglio F; Paterniti I; Mazzon E; Oteri G; Militi D; Cordasco G; Cuzzocrea S
Mediators Inflamm; 2011; 2011():787159. PubMed ID: 22131647
[TBL] [Abstract][Full Text] [Related]
26. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism.
Lee MY; Choi R; Kim HM; Cho EJ; Kim BH; Choi YS; Naowaboot J; Lee EY; Yang YC; Shin JY; Shin YG; Chung CH
Exp Mol Med; 2012 Oct; 44(10):578-85. PubMed ID: 22824914
[TBL] [Abstract][Full Text] [Related]
28. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
29. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
[TBL] [Abstract][Full Text] [Related]
30. Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.
Wang C; Zhou G; Zeng Z
Chin Med J (Engl); 2014; 127(11):2129-37. PubMed ID: 24890166
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.
Collino M; Benetti E; Miglio G; Castiglia S; Rosa AC; Aragno M; Thiemermann C; Fantozzi R
Free Radic Biol Med; 2011 Jan; 50(2):345-53. PubMed ID: 21047550
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
33. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization.
Tobita Y; Arima T; Nakano Y; Uchiyama M; Shimizu A; Takahashi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722564
[TBL] [Abstract][Full Text] [Related]
35. PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
An YQ; Zhang CT; Du Y; Zhang M; Tang SS; Hu M; Long Y; Sun HB; Hong H
Metab Brain Dis; 2016 Jun; 31(3):663-71. PubMed ID: 26864581
[TBL] [Abstract][Full Text] [Related]
36. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
37. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
[TBL] [Abstract][Full Text] [Related]
38. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
[TBL] [Abstract][Full Text] [Related]
39. Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742.
Haskova Z; Hoang B; Luo G; Morgan LA; Billin AN; Barone FC; Shearer BG; Barton ME; Kilgore KS
Inflamm Res; 2008 Jul; 57(7):314-21. PubMed ID: 18622687
[TBL] [Abstract][Full Text] [Related]
40. PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells.
Shan J; Kimura H; Yokoi S; Kamiyama K; Imamoto T; Takeda I; Kobayashi M; Mikami D; Takahashi N; Kasuno K; Sugaya T; Iwano M
Clin Exp Nephrol; 2021 Jun; 25(6):598-607. PubMed ID: 33646450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
